Kirk K. Calhoun - Feb 22, 2022 Form 4 Insider Report for PLx Pharma Inc. (PLXPQ)

Role
Director
Signature
/s/ Natasha Giordano, as Attorney-in-Fact
Stock symbol
PLXPQ
Transactions as of
Feb 22, 2022
Transactions value $
$0
Form type
4
Date filed
2/24/2022, 07:11 PM
Previous filing
Jul 26, 2021
Next filing
Jun 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLXPQ Stock Option (right to buy) Award $0 +20K $0.00 20K Feb 22, 2022 Common Stock 20K $4.99 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan, as amended.
F2 These stock options vest in full on the first anniversary of the grant date.